Reynosin is primarily used in scientific research for its biological activity, particularly in the study of anti-inflammatory and immunomodulatory effects. It inhibits inflammatory mediators involved in chronic diseases such as rheumatoid arthritis and atopic dermatitis. Studies indicate that reynosin disrupts cellular signaling pathways related to cytokine production, such as TNF-α and IL-6, potentially leading to the development of new therapeutic agents for chronic inflammatory conditions. Additionally, reynosin exhibits antioxidant activity at the cellular level and shows cytotoxicity against cancer cell lines in vitro, contributing to its evaluation in anticancer research. Its interactions with cellular signaling molecules make it a valuable biochemical tool in pharmacological studies and a potential starting compound for designing bioactive agents.